Health Care / Medicine
-
Health Care / Medicine
Moody’s Report: Health Insurers Will Remain Profitable After Pandemic
A report released Tuesday by Moody’s Investors Service predicted that most insurers will remain profitable after the COVID-19 pandemic. -
Health Care / Medicine
Is Hydroxychloroquine Hype Hampering Enrollment In Gilead’s Covid-19 Drug Trials?
Two investigators in Gilead's Phase III remdesivir trials were unsurprised at recent protocol changes. However, they said enrollment in the moderate-disease study was slow due to difficulty capturing those patients, with one also citing publicity-driven interest in two unproven malaria drugs. - Sponsored
AI’s Impact On Law Firms Of Every Size
How solo lawyers, midsize firms, and global large law firms have an opportunity to adjust the way they work. -
Health Care / Medicine
FCC Proposes $200M Telehealth Program To Tackle COVID-19
Commissioners still must approve the fund before providers can submit their proposals.
-
Health Care / Medicine
How Have These Firms Making COVID-19 News Fared As Stock Markets Have Tanked?
While all these companies have been involved in developing testing, vaccines, and drugs for SARS-CoV-2, fears related to the global coronavirus pandemic have taken their toll on them as well as firms in other sectors. -
Health Care / Medicine
We Are Failing Women Of Color And It Is Fatal -- A Discussion With Hampton, NCCU Law Alum Nickeyea Wilkinson and Howard, NYU Alum Ashlee Wisdom
'The cost and access to healthcare for many people with lower socioeconomic status, or who have been historically underserved, are huge problems within our healthcare system.' -
Health Care / Medicine, Intellectual Property
Do Androids Dream Of Electric Lawsuits? Current IP Law Ill-Suited For AI In Drug Discovery, Panelist Says
The question of who owns the intellectual property to a drug born inside a computer came up in a panel discussion at a recent life sciences law symposium. -
Health Care / Medicine
FDA Chief Reports First Drug Shortage Due To Coronavirus
While he did not identify the manufacturer or the drug in question, FDA Commissioner Stephen Hahn said there were alternatives to it. The FDA has asked more than 180 drugmakers to evaluate their supply chains amid the growing coronavirus outbreak. -
Health Care / Medicine
Senators Threaten To Subpoena Cigna In Insulin Cost Probe
Senators Chuck Grassley and Ron Wyden are demanding that Cigna turn over documents on insulin pricing, as part of a larger probe on rising insulin costs. The lawmakers claim that large pharmacy benefit manager Express Scripts, which Cigna acquired in 2018, is failing to comply with the investigation. - Sponsored
Law Firms Now Have A Choice In Their Document Comparison Software
Six months on since its launch, over 200 firms worldwide are now using Draftable Legal for accurate and reliable document comparison, including UK Top 50… -
Health Care / Medicine
Here Are The Leading Companies Enlisting In The Fight Against Coronavirus
More than 80,000 people worldwide have been infected with the SARS-CoV-2 virus. In response, the U.S. government has partnered with several companies to develop drugs to treat the infection and vaccines to prevent it. -
Health Care / Medicine, Intellectual Property
A Short History Of Drug Patent Expirations
This eBook offers an overview of drug patents that were and are set to expire and highlights efforts by the FDA to stimulate the market for generics. -
Health Care / Medicine
Misleading HIV Drug Lawsuit Ads Still Appear On Facebook Despite Effort To Remove Them
The social media company last month began taking down ads for lawsuits over Gilead's Truvada after complaints from LGBT and HIV organizations. However, several such ads have continued appearing on the platform, including one updated Monday that linked the drug to injuries. -
Courts, Health Care / Medicine
Appeals Court Strikes Down Arkansas Work Requirements
A three-judge panel unanimously upheld a previous ruling that the Department of Health and Human Services failed to consider whether the work requirements would fulfill Medicaid's core objective of providing health care to low-income families. -
Health Care / Medicine, Intellectual Property
Biogen Fends Off Mylan’s Challenge To Patent On Multiple Sclerosis Drug
The Patent Trial and Appeal Board ruled against the generic drugmaker's inter partes review seeking to overturn the patent covering Tecfidera. The drug, which had $4.4 billion in sales last year, could remain protected through February 2028.
Sponsored
Sponsored
Why Do AI And Legal Professionals Make The Perfect Partnership?
For many legal departments, generative AI is the technology they’ve been waiting for.
Sponsored
Diving Into Generative AI: A Practical Guide For Law Firms Starting From Scratch
NetDocuments’ Michelle Spencer on where to start, what to ask, and considerations for implementing generative AI tools in your organization.
Sponsored
AI’s Impact On Law Firms Of Every Size
How solo lawyers, midsize firms, and global large law firms have an opportunity to adjust the way they work.
Sponsored
Sponsored
Gain An Instant Understanding Of New Complaints With LexisNexis Snapshot
AI-powered complaint summaries to help you spot new lawsuits, new challenges, and new business.
Sponsored
Law Firms Now Have A Choice In Their Document Comparison Software
Six months on since its launch, over 200 firms worldwide are now using Draftable Legal for accurate and reliable document comparison, including UK Top 50…
-
Health Care / Medicine, Intellectual Property
These Drug Patents Are Expected To Expire In 2020
According to a report, drugmakers are expected to lose $17 billion in worldwide sales due to patent expirations this year. -
Health Care / Medicine
Health IT Company To Pay Fine Over Alleged Kickback Scheme To Influence Opioid Prescriptions
Practice Fusion will pay $145 million to resolve criminal and civil allegations that it received kickbacks from an unnamed pharmaceutical company in exchange for building a clinical decision support system that could influence opioid prescriptions. The system generated more than 230 million alerts between 2016 and 2019, according to court documents. -
Health Care / Medicine
Hospitals Sue CMS Again Over Site-Neutral Payments
The American Hospital Association and the Association of American Medical Colleges sued CMS over a planned $800 million reduction in payments for hospital outpatient services in 2020. The two groups won a similar lawsuit in 2019. -
Health Care / Medicine
Startup Aims To Tackle High Drug Prices With $200M Series A Financing
The startup, founded by a prominent health policy expert and a biotech industry executive, aims to bring down the cost of drugs by re-engineering and making less costly the process by which they are discovered and brought to patients. -
Health Care / Medicine
Women’s Health Startup Pulls In $45M To Support Growth
The startup which provides care by blending technology and physical clinics wants to change how women get care. First, it has to find OB/GYNs. -
Health Care / Medicine
Black Diamond, Targeting Untapped Cancer Mutations, Files For $100M IPO
Just a little over a year after it emerged from stealth mode, the company - which recently initiated a clinical trial of a drug targeting allosteric mutations in solid tumors - has filed to go public. -
Health Care / Medicine
M&A Doesn't Help: Hospitals Edition
The study, published in the New England Journal of Medicine, showed a decline in patient experience after hospitals had merged.